Biosimilar Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biosimilar Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Overall Market Size
2.1 Global Biosimilar Market Size: 2021 VS 2027
2.2 Global Biosimilar Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Biosimilar Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Biosimilar Players in Global Market
3.2 Top Global Biosimilar Companies Ranked by Revenue
3.3 Global Biosimilar Revenue by Companies
3.4 Global Biosimilar Sales by Companies
3.5 Global Biosimilar Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Biosimilar Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Biosimilar Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilar Players in Global Market
3.8.1 List of Global Tier 1 Biosimilar Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilar Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar Market Size Markets, 2021 & 2027
4.1.2 Human Growth Hormones
4.1.3 Monoclonal Antibodies
4.1.4 Insulin
4.1.5 Peptides
4.1.6 Erythropoietin
4.1.7 Others
4.2 By Type - Global Biosimilar Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Revenue, 2016-2021
4.2.2 By Type - Global Biosimilar Revenue, 2022-2027
4.2.3 By Type - Global Biosimilar Revenue Market Share, 2016-2027
4.3 By Type - Global Biosimilar Sales & Forecasts
4.3.1 By Type - Global Biosimilar Sales, 2016-2021
4.3.2 By Type - Global Biosimilar Sales, 2022-2027
4.3.3 By Type - Global Biosimilar Sales Market Share, 2016-2027
4.4 By Type - Global Biosimilar Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Chronic and Autoimmune Diseases
5.1.4 Growth Hormone Deficiency
5.1.5 Infectious Diseases
5.1.6 Others
5.2 By Application - Global Biosimilar Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Revenue, 2016-2021
5.2.2 By Application - Global Biosimilar Revenue, 2022-2027
5.2.3 By Application - Global Biosimilar Revenue Market Share, 2016-2027
5.3 By Application - Global Biosimilar Sales & Forecasts
5.3.1 By Application - Global Biosimilar Sales, 2016-2021
5.3.2 By Application - Global Biosimilar Sales, 2022-2027
5.3.3 By Application - Global Biosimilar Sales Market Share, 2016-2027
5.4 By Application - Global Biosimilar Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Biosimilar Market Size, 2021 & 2027
6.2 By Region - Global Biosimilar Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Revenue, 2016-2021
6.2.2 By Region - Global Biosimilar Revenue, 2022-2027
6.2.3 By Region - Global Biosimilar Revenue Market Share, 2016-2027
6.3 By Region - Global Biosimilar Sales & Forecasts
6.3.1 By Region - Global Biosimilar Sales, 2016-2021
6.3.2 By Region - Global Biosimilar Sales, 2022-2027
6.3.3 By Region - Global Biosimilar Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Biosimilar Revenue, 2016-2027
6.4.2 By Country - North America Biosimilar Sales, 2016-2027
6.4.3 US Biosimilar Market Size, 2016-2027
6.4.4 Canada Biosimilar Market Size, 2016-2027
6.4.5 Mexico Biosimilar Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Biosimilar Revenue, 2016-2027
6.5.2 By Country - Europe Biosimilar Sales, 2016-2027
6.5.3 Germany Biosimilar Market Size, 2016-2027
6.5.4 France Biosimilar Market Size, 2016-2027
6.5.5 U.K. Biosimilar Market Size, 2016-2027
6.5.6 Italy Biosimilar Market Size, 2016-2027
6.5.7 Russia Biosimilar Market Size, 2016-2027
6.5.8 Nordic Countries Biosimilar Market Size, 2016-2027
6.5.9 Benelux Biosimilar Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Biosimilar Revenue, 2016-2027
6.6.2 By Region - Asia Biosimilar Sales, 2016-2027
6.6.3 China Biosimilar Market Size, 2016-2027
6.6.4 Japan Biosimilar Market Size, 2016-2027
6.6.5 South Korea Biosimilar Market Size, 2016-2027
6.6.6 Southeast Asia Biosimilar Market Size, 2016-2027
6.6.7 India Biosimilar Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Biosimilar Revenue, 2016-2027
6.7.2 By Country - South America Biosimilar Sales, 2016-2027
6.7.3 Brazil Biosimilar Market Size, 2016-2027
6.7.4 Argentina Biosimilar Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilar Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Biosimilar Sales, 2016-2027
6.8.3 Turkey Biosimilar Market Size, 2016-2027
6.8.4 Israel Biosimilar Market Size, 2016-2027
6.8.5 Saudi Arabia Biosimilar Market Size, 2016-2027
6.8.6 UAE Biosimilar Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Allergan plc
7.1.1 Allergan plc Corporate Summary
7.1.2 Allergan plc Business Overview
7.1.3 Allergan plc Biosimilar Major Product Offerings
7.1.4 Allergan plc Biosimilar Sales and Revenue in Global (2016-2021)
7.1.5 Allergan plc Key News
7.2 BIOCAD
7.2.1 BIOCAD Corporate Summary
7.2.2 BIOCAD Business Overview
7.2.3 BIOCAD Biosimilar Major Product Offerings
7.2.4 BIOCAD Biosimilar Sales and Revenue in Global (2016-2021)
7.2.5 BIOCAD Key News
7.3 Biocon
7.3.1 Biocon Corporate Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Biosimilar Major Product Offerings
7.3.4 Biocon Biosimilar Sales and Revenue in Global (2016-2021)
7.3.5 Biocon Key News
7.4 BioXpress Therapeutics
7.4.1 BioXpress Therapeutics Corporate Summary
7.4.2 BioXpress Therapeutics Business Overview
7.4.3 BioXpress Therapeutics Biosimilar Major Product Offerings
7.4.4 BioXpress Therapeutics Biosimilar Sales and Revenue in Global (2016-2021)
7.4.5 BioXpress Therapeutics Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Biosimilar Major Product Offerings
7.5.4 Boehringer Ingelheim Biosimilar Sales and Revenue in Global (2016-2021)
7.5.5 Boehringer Ingelheim Key News
7.6 Celltrion
7.6.1 Celltrion Corporate Summary
7.6.2 Celltrion Business Overview
7.6.3 Celltrion Biosimilar Major Product Offerings
7.6.4 Celltrion Biosimilar Sales and Revenue in Global (2016-2021)
7.6.5 Celltrion Key News
7.7 Coherus BioSciences
7.7.1 Coherus BioSciences Corporate Summary
7.7.2 Coherus BioSciences Business Overview
7.7.3 Coherus BioSciences Biosimilar Major Product Offerings
7.4.4 Coherus BioSciences Biosimilar Sales and Revenue in Global (2016-2021)
7.7.5 Coherus BioSciences Key News
7.8 Dr. Reddy's Laboratories
7.8.1 Dr. Reddy's Laboratories Corporate Summary
7.8.2 Dr. Reddy's Laboratories Business Overview
7.8.3 Dr. Reddy's Laboratories Biosimilar Major Product Offerings
7.8.4 Dr. Reddy's Laboratories Biosimilar Sales and Revenue in Global (2016-2021)
7.8.5 Dr. Reddy's Laboratories Key News
7.9 Genor BioPharma
7.9.1 Genor BioPharma Corporate Summary
7.9.2 Genor BioPharma Business Overview
7.9.3 Genor BioPharma Biosimilar Major Product Offerings
7.9.4 Genor BioPharma Biosimilar Sales and Revenue in Global (2016-2021)
7.9.5 Genor BioPharma Key News
7.10 Intas Pharmaceuticals Limited
7.10.1 Intas Pharmaceuticals Limited Corporate Summary
7.10.2 Intas Pharmaceuticals Limited Business Overview
7.10.3 Intas Pharmaceuticals Limited Biosimilar Major Product Offerings
7.10.4 Intas Pharmaceuticals Limited Biosimilar Sales and Revenue in Global (2016-2021)
7.10.5 Intas Pharmaceuticals Limited Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Biosimilar Business Overview
7.11.3 Novartis Biosimilar Major Product Offerings
7.11.4 Novartis Biosimilar Sales and Revenue in Global (2016-2021)
7.11.5 Novartis Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Biosimilar Business Overview
7.12.3 Pfizer Biosimilar Major Product Offerings
7.12.4 Pfizer Biosimilar Sales and Revenue in Global (2016-2021)
7.12.5 Pfizer Key News
8 Global Biosimilar Production Capacity, Analysis
8.1 Global Biosimilar Production Capacity, 2016-2027
8.2 Biosimilar Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilar Supply Chain Analysis
10.1 Biosimilar Industry Value Chain
10.2 Biosimilar Upstream Market
10.3 Biosimilar Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Biosimilar in Global Market
Table 2. Top Biosimilar Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Biosimilar Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Biosimilar Revenue Share by Companies, 2016-2021
Table 5. Global Biosimilar Sales by Companies, (K Units), 2016-2021
Table 6. Global Biosimilar Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Biosimilar Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Biosimilar Product Type
Table 9. List of Global Tier 1 Biosimilar Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Biosimilar Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Biosimilar Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Biosimilar Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Biosimilar Sales (K Units), 2016-2021
Table 15. By Type - Global Biosimilar Sales (K Units), 2022-2027
Table 16. By Application - Global Biosimilar Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Biosimilar Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Biosimilar Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Biosimilar Sales (K Units), 2016-2021
Table 20. By Application - Global Biosimilar Sales (K Units), 2022-2027
Table 21. By Region - Global Biosimilar Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Biosimilar Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Biosimilar Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Biosimilar Sales (K Units), 2016-2021
Table 25. By Region - Global Biosimilar Sales (K Units), 2022-2027
Table 26. By Country - North America Biosimilar Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Biosimilar Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Biosimilar Sales, (K Units), 2016-2021
Table 29. By Country - North America Biosimilar Sales, (K Units), 2022-2027
Table 30. By Country - Europe Biosimilar Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Biosimilar Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Biosimilar Sales, (K Units), 2016-2021
Table 33. By Country - Europe Biosimilar Sales, (K Units), 2022-2027
Table 34. By Region - Asia Biosimilar Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Biosimilar Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Biosimilar Sales, (K Units), 2016-2021
Table 37. By Region - Asia Biosimilar Sales, (K Units), 2022-2027
Table 38. By Country - South America Biosimilar Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Biosimilar Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Biosimilar Sales, (K Units), 2016-2021
Table 41. By Country - South America Biosimilar Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Biosimilar Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Biosimilar Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Biosimilar Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Biosimilar Sales, (K Units), 2022-2027
Table 46. Allergan plc Corporate Summary
Table 47. Allergan plc Biosimilar Product Offerings
Table 48. Allergan plc Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. BIOCAD Corporate Summary
Table 50. BIOCAD Biosimilar Product Offerings
Table 51. BIOCAD Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. Biocon Corporate Summary
Table 53. Biocon Biosimilar Product Offerings
Table 54. Biocon Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. BioXpress Therapeutics Corporate Summary
Table 56. BioXpress Therapeutics Biosimilar Product Offerings
Table 57. BioXpress Therapeutics Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. Boehringer Ingelheim Corporate Summary
Table 59. Boehringer Ingelheim Biosimilar Product Offerings
Table 60. Boehringer Ingelheim Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. Celltrion Corporate Summary
Table 62. Celltrion Biosimilar Product Offerings
Table 63. Celltrion Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. Coherus BioSciences Corporate Summary
Table 65. Coherus BioSciences Biosimilar Product Offerings
Table 66. Coherus BioSciences Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. Dr. Reddy's Laboratories Corporate Summary
Table 68. Dr. Reddy's Laboratories Biosimilar Product Offerings
Table 69. Dr. Reddy's Laboratories Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 70. Genor BioPharma Corporate Summary
Table 71. Genor BioPharma Biosimilar Product Offerings
Table 72. Genor BioPharma Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 73. Intas Pharmaceuticals Limited Corporate Summary
Table 74. Intas Pharmaceuticals Limited Biosimilar Product Offerings
Table 75. Intas Pharmaceuticals Limited Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 76. Novartis Corporate Summary
Table 77. Novartis Biosimilar Product Offerings
Table 78. Novartis Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 79. Pfizer Corporate Summary
Table 80. Pfizer Biosimilar Product Offerings
Table 81. Pfizer Biosimilar Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 82. Biosimilar Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 83. Global Biosimilar Capacity Market Share of Key Manufacturers, 2019-2021
Table 84. Global Biosimilar Production by Region, 2016-2021 (K Units)
Table 85. Global Biosimilar Production by Region, 2022-2027 (K Units)
Table 86. Biosimilar Market Opportunities & Trends in Global Market
Table 87. Biosimilar Market Drivers in Global Market
Table 88. Biosimilar Market Restraints in Global Market
Table 89. Biosimilar Raw Materials
Table 90. Biosimilar Raw Materials Suppliers in Global Market
Table 91. Typical Biosimilar Downstream
Table 92. Biosimilar Downstream Clients in Global Market
Table 93. Biosimilar Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biosimilar Segment by Type
Figure 2. Biosimilar Segment by Application
Figure 3. Global Biosimilar Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biosimilar Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Biosimilar Revenue, 2016-2027 (US$, Mn)
Figure 7. Biosimilar Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilar Revenue in 2020
Figure 9. By Type - Global Biosimilar Sales Market Share, 2016-2027
Figure 10. By Type - Global Biosimilar Revenue Market Share, 2016-2027
Figure 11. By Type - Global Biosimilar Price (US$/Unit), 2016-2027
Figure 12. By Application - Global Biosimilar Sales Market Share, 2016-2027
Figure 13. By Application - Global Biosimilar Revenue Market Share, 2016-2027
Figure 14. By Application - Global Biosimilar Price (US$/Unit), 2016-2027
Figure 15. By Region - Global Biosimilar Sales Market Share, 2016-2027
Figure 16. By Region - Global Biosimilar Revenue Market Share, 2016-2027
Figure 17. By Country - North America Biosimilar Revenue Market Share, 2016-2027
Figure 18. By Country - North America Biosimilar Sales Market Share, 2016-2027
Figure 19. US Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Biosimilar Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Biosimilar Sales Market Share, 2016-2027
Figure 24. Germany Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 25. France Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Biosimilar Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Biosimilar Sales Market Share, 2016-2027
Figure 33. China Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 37. India Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Biosimilar Revenue Market Share, 2016-2027
Figure 39. By Country - South America Biosimilar Sales Market Share, 2016-2027
Figure 40. Brazil Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Biosimilar Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Biosimilar Sales Market Share, 2016-2027
Figure 44. Turkey Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Biosimilar Revenue, (US$, Mn), 2016-2027
Figure 48. Global Biosimilar Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Biosimilar by Region, 2020 VS 2027
Figure 50. Biosimilar Industry Value Chain
Figure 51. Marketing Channels

Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy's Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer